NewsRx

Search our medical news database

Quigley

Quigley compound QR-443 effective in preventing cachexia

Published in AIDS Weekly and Law, September 7th, 2006

Quigley Pharma has obtained positive results for its QR-443 compound for the treatment of cachexia, a debilitating and life threatening muscle wasting condition. The results of an animal study found a 75% efficacy rate in the treatment of mice with this condition.

The results of the study clearly indicated that 75% of the tested mice injected with 5 mg of QR-433 were protected from cachexia and did not exhibit any significant weight loss compared to untreated control animals which exhibited a 15-25 percent weight loss at the end of the experiment.

Cachexia, an extremely debilitating and life threatening condition, is a loss of weight, muscle wasting,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly and Law


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook